Mexico Attention Deficit Hyperactivity Disorder Market Size & Outlook
Mexico attention deficit hyperactivity disorder market, 2018-2030 (US$M)
Related Markets
Mexico attention deficit hyperactivity disorder market highlights
- The Mexico attention deficit hyperactivity disorder market generated a revenue of USD 63.9 million in 2023 and is expected to reach USD 83.4 million by 2030.
- The Mexico market is expected to grow at a CAGR of 3.9% from 2024 to 2030.
- In terms of segment, stimulants was the largest revenue generating drug type in 2023.
- Non-stimulants is the most lucrative drug type segment registering the fastest growth during the forecast period.
Attention deficit hyperactivity disorder market data book summary
| Market revenue in 2023 | USD 63.9 million |
| Market revenue in 2030 | USD 83.4 million |
| Growth rate | 3.9% (CAGR from 2023 to 2030) |
| Largest segment | Stimulants |
| Fastest growing segment | Non-stimulants |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stimulants, Non-stimulants |
| Key market players worldwide | Eli Lilly and Co, Pfizer Inc, Johnson & Johnson, Lupin, Novartis AG ADR, Takeda Pharmaceutical Co Ltd, Mallinckrodt PLC Ordinary Shares - New, Vital KSK Holdings Inc, NeuroSense Therapeutics Ltd, Supernus Pharmaceuticals Inc |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.4% of the global attention deficit hyperactivity disorder market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil attention deficit hyperactivity disorder market is projected to lead the regional market in terms of revenue in 2030.
- Mexico is the fastest growing regional market in Latin America and is projected to reach USD 83.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Attention Deficit Hyperactivity Disorder Market Scope
Attention Deficit Hyperactivity Disorder Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico attention deficit hyperactivity disorder market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to attention deficit hyperactivity disorder market will help companies and investors design strategic landscapes.
Stimulants was the largest segment with a revenue share of 70.89% in 2023. Horizon Databook has segmented the Mexico attention deficit hyperactivity disorder market based on stimulants, non-stimulants covering the revenue growth of each sub-segment from 2018 to 2030.
Mexico is the second largest market after Brazil in Latin America. In Mexico, Vyvanse and Strattera are authorized by COFEPRIS for treating ADHD. Vyvanse is the only approved prodrug stimulant indicated for the treatment of ADHD patients aged 6 to 12 years. It is administered orally, with an onset within 2 hours, lasting up to 14 hours.
However, the persistent shortage of Adderall in the U.S. has led to a concerning market impact, with some Mexican pharmacies selling counterfeit versions over the counter. Despite bearing the names and logos of reputable pharmaceutical companies, these fake medications often contain substances such as methamphetamine, appetite suppressants, acetaminophen, or caffeine.
The availability of counterfeit Adderall raises serious health risks for consumers. While Mexican drug regulators have initiated crackdowns with raids and seizures in response, the market impact is marked by the potential harm to unsuspecting individuals seeking legitimate medication, emphasizing the need for enhanced regulatory measures to address such issues.
Reasons to subscribe to Mexico attention deficit hyperactivity disorder market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico attention deficit hyperactivity disorder market databook
-
Our clientele includes a mix of attention deficit hyperactivity disorder market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico attention deficit hyperactivity disorder market , including forecasts for subscribers. This country databook contains high-level insights into Mexico attention deficit hyperactivity disorder market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico attention deficit hyperactivity disorder market size, by drug type, 2018-2030 (US$M)
Mexico Attention Deficit Hyperactivity Disorder Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
